MALLINCKRODT BAKER, INC. -- BARIUM NITRATE -- 6810-00-174-9658
===================== Product Identification =====================
Product ID:BARIUM NITRATE
MSDS Date:11/16/1999
FSC:6810
NIIN:00-174-9658
=== Responsible Party ===
Company Name:MALLINCKRODT BAKER, INC.
Address:222 RED SCHOOL LANE
City:PHILLIPSBURG
State:NJ
ZIP:08865-2219
Country:US
Info Phone Num:908-859-2151/ 800-582-2537
Emergency Phone Num:800-424-9300
Resp. Party Other MSDS Num.:B0432
Chemtrec Ind/Phone:(800)424-9300
CAGE:70829
=== Contractor Identification ===
Company Name:COLUMBUS CHEMICAL INDUSTRIES INC
Address:N 4335 TEMKIN RD
Box:8
City:COLUMBUS
State:WI
ZIP:53925-0008
Country:US
Phone:920-623-2140
CAGE:5Y144
Company Name:MALLINCKRODT BAKER, INC.
Address:222 RED SCHOOL LANE
Box:City:PHILLIPSBURG
State:NJ
ZIP:08865
Country:US
Phone:800-582-2537
CAGE:70829
Company Name:PHOENIX INDUSTRIES INC
Address:1519 CHAMBERLAYNE PARKWAY
Box:City:RICHMOND
State:VA
ZIP:23222
Country:US
Phone:804-264-5183/FAX: 264-5535
Contract Num:SP0450-01-M-D335
CAGE:0YED2
============= Composition/Information on Ingredients =============
Ingred Name:BARIUM NITRATE
CAS:10022-31-8
RTECS #:CQ9625000
Minumum % Wt:99.
Maxumum % Wt:100.
OSHA PEL:0.5 MG/M3 (BA)
ACGIH TLV:0.5 MG/M3 (BA); 8990
===================== Hazards Identification =====================
LD50 LC50 Mixture:ORAL RAT LD50: 355 MG/KG.
Routes of Entry: Inhalation:YES Skin:YES Ingestion:YES
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:INHALATION CAUSES IRRITATION TO
RESPIRATORY TRACT. INGESTION: MAY CAUSE TIGHTNESS OF MUSCLES OF
FACE AND NECK . MAY CAUSE KIDNEY DAMAGE. SKIN/EYE CONTACT CAUSES
IRRITATION. REPEATED CONTACT WITH LIQU ID MAY CAUSE DRYNESS,
CRACKING, SKIN IRRITATION. CAUSES EYE IRRITATION. AFFECTS THE
CENTRAL NERVOUS SYSTEM. CHRONIC EFFECTS MAY BE SIMILAR TO THOSE
FROM METHANOL EXPOSURE BECAUSE METHYL ACETATE CAN BE HYDROLYZED
YIELDING METHANOL AND ACETIC ACID. OPTIC NERVE DAMAGE IS THE
PREDOMINANT HAZARD.
Explanation of Carcinogenicity:THIS COMPOUND CONTAINS NO INGREDIENTS AT
CONCENTRATIONS OF 0.1% OR GREATER THAT ARE CARCINOGENS OR SUSPECT
CARCINOGENS.
Effects of Overexposure:COUGHING, SHORTNESS OF BREATH, TIGHTNESS OF
MUSCLES OF FACE AND NECK, VOMITING, DIARRHEA, ABDOMINAL PAIN,
MUSCULAR TREMORS, ANXIETY, WEAKNESS, LABORED BREATHING, CARDIAC
IRREGULARITY, CONVULSIONS, DEA TH FROM CARDIAC AND RESPIRATORY
FAILURE, SKIN IRRITATION, ITCHING, PAIN, EYE IRRITATION, REDNESS,
PAIN. MAY CAUSE KIDNEY DAMAGE.
Medical Cond Aggravated by Exposure:PERSONS WITH PRE-EXISTING SKIN AND
NERVOUS SYSTEM DISORDERS OR IMPAIRED RESPIRATORY OR KIDNEY FUNCTION
MAY BE MORE SUSCEPTIBLE TO THE EFFECTS OF THIS SUBSTANCE.
======================= First Aid Measures =======================
First Aid:EYES: IMMEDIATELY FLUSH WITH WATER FOR AT LEAST 15 MINUTES,
LIFTING UPPER AND LOWER EYELIDS OCCASIONALLY. GET MEDICAL
ATTENTION. SKIN: FLUSH WITH WATER FOR AT LEAST 15 MINUTES. REMOVE
CLOTHING AND SHO ES. GET MEDICAL ATTENTION. INHALATION: REMOVE TO
FRESH AIR. IF NOT BREATHING, GIVE ARTIFICIAL RESPIRATION. IF
BREATHING IS DIFFICULT, GIVE OXYGEN. GET MEDICAL HELP. INGESTION:
GET MEDICAL ATTENTION IM MEDIATELY. INDUCE VOMITING AS DIRECTED BY
MEDICAL PERSONNEL. NEVER GIVE ANYTHING BY MOUTH TO AN UNCONSCIOUS
PERSON. SEE NEUTRALIZING AGENT.
===================== Fire Fighting Measures =====================
Flash Point:NONE
Lower Limits:NOT GIVEN
Upper Limits:NOT GIVEN
Extinguishing Media:FOAM, DRY CHEMICAL, CARBON DIOXIDE, FLOODING
AMOUNTS OF WATER IN EARLY STAGES OF FIRE. DO NOT USE WATER ON
MOLTEN MATERIAL.
Fire Fighting Procedures:WEAR FULL PROTECTIVE CLOTHING AND
NIOSH-APPROVED SELF-CONTAINED BREATHING APPARATUS WITH FULL
FACEPIECE OPERATED IN THE PRESSURE DEMAND OR OTHER POSITIVE
PRESSURE MODE.
Unusual Fire/Explosion Hazard:DO NOT RELEASE RUNOFF FROM FIRE CONTROL
METHODS TO SEWERS OR WATERWAYS. STRONG OXIDIZER AND ITS HEAT OF
REACTION WITH REDUCING AGENTS/COMBUSTIBLES MAY IGNITE. CONTACT WITH
OXIDIZABLE SUBSTANCES MAY CA USE EXTREMELY VIOLENT COMBUSTION.
EMITS NITROGEN OXIDES WHEN HEATED TO DECOMPOSITION.
================== Accidental Release Measures ==================
Spill Release Procedures:VENTILATE AREA OF SPILL. KEEP UNNECESSARY AND
UNPROTECTED PEOPLE AWAY FROM AREA OF SPILL. WEAR APPROPRIATE
PERSONAL PROTECTIVE EQUIPMENT. PICK UP AND PLACE IN A SUITABLE
CONTAINER FOR RECLAMATION OR DISPOSAL, USING A METHOD THAT DOES
NOT GENERATE DUST.
Neutralizing Agent:AFTER VOMITING, A MIXTURE OF 1 TABLESPOON OF SODIUM
OR MAGNESIUM SULFATE(EPSOM SALTS) DISSOLVED IN 8 OZ OF WATER
====================== Handling and Storage ======================
Handling and Storage Precautions:KEEP IN TIGHTLY CLOSED CONTAINER,
STORED IN A COOL, DRY, VENTILATED AREA. PROTECT AGAINST PHYSICAL
DAMAGE. ISOLATE FROM INCOMPATIBLES.
Other Precautions:SEPARATE FROM COMBUSTIBLES, ORGANIC OR OTHER READILY
OXIDIZABLE MATERIALS. AVOID STORAGE ON WOODEN FLOORS. CONTAINER OF
THIS MATERIAL MAY BE HAZARDOUS WHEN EMPTY SINCE THEY RETAIN PRODUCT
RESIDUES; OB SERVE ALL WARNINGS AND PRECAUTIONS LISTED FOR THE
PRODUCT.
============= Exposure Controls/Personal Protection =============
Respiratory Protection:IF THE EXPOSURE LIMIT IS EXCEEDED, A FULL
FACEPIECE RESPIRATOR WITH DUST/MIST FILTER MAY BE WORN UP TO 50
TIMES THE EXPOSURE LIMIT OR MAXIMUM USE CONCENTRATION SPECIFIED BY
THE APPROPRIATE REGULATORY AGENCY OR REPSIRATOR SUPPLIER.
Ventilation:A SYSTEM OF LOCAL/GENERAL EXHAUST IS RECOMMENDED TO KEEP
EMPLOYEE EXPOSURES BELOW EXPOSURE LIMITS.
Protective Gloves:IMPERVIOUS
Eye Protection:CHEMICAL SAFETY GOGGLES
Other Protective Equipment:WEAR IMPERVIOUS PROTECTIVE CLOTHING,
INCLUDING BOOTS, GLOVES, LAB COAT, APRON OR COVERALLS, AS NECESSARY
TO PREVENT SKIN CONTACT. AN EMERGENCY EYEWASH AND QUICK DRENCH
SHOWER SHOULD BE AVAILABLE.
Work Hygienic Practices:WASH HANDS THOROUGHLY WITH SOAP AND WATER
BEFORE EATING, DRINKING, SMOKING OR USING TOILET FACILITIES.
Supplemental Safety and Health
NOTE TO PHYSICIAN: MONITOR PATIENTS WITH SIGNIFICANT INGESTION FOR
RESPIRATORY, CARDIOVASCULAR, AND BLOOD PRESSURE STATUS. WATCH FOR
CARDIAC ARRHYTHMIAS, RESPIRATORY FAILURE DUE TO FLACCID PARALYSIS O
R RESPIRATORY MUSCLES, PULMONARY EDEMA,VOCAL CORD PARALYSIS, SEVERE
HYPERTENSION & LATE EFFECT KIDNEY FAILURE.
================== Physical/Chemical Properties ==================
HCC:D1
Boiling Pt:B.P. Text:DECOMPOSES
Melt/Freeze Pt:=592.C, ######F
Decomp Temp:Decomp Text:NOT GIVEN
Vapor Pres:NO INFORMATION GIVEN
Vapor Density:NO INFORMA
Evaporation Rate & Reference:NOT GIVEN
Solubility in Water:8.7 GRAMS/100G
Appearance and Odor:WHITE CRYSTALS, NO ODOR.
================= Stability and Reactivity Data =================
Stability Indicator/Materials to Avoid:YES
MAGNESIUM PLUS BARIUM OXIDE PLUS ZINC, ALUMINUM AND MAGNESIUM ALLOYS,
COMBUSTIBLES, (PAPER, OIL, WOOD), ACIDS, OXIDIZERS.
Stability Condition to Avoid:NONE SPECIFIED BY MANUFACTURER.
Hazardous Decomposition Products:OXIDES OF NITROGEN AND TOXIC METAL
FUMES
=================== Toxicological Information ===================
Toxicological Information:FOR BARIUM NITRATE: ORAL RAT LD50: 355 MG/KG.
IRRITATION DATA: SKIN RABBIT 500 MG/24H MILD. EYE RABBIT 100
MG/24H SEVERE.
===================== Ecological Information =====================
Ecological:ENVIRONMENTAL FATE: THIS MATERIAL MAY BIOACCUMULATE TO SOME
EXTENT. ENVIRONMENTAL TOXICITY: NO INFORMATION FOUND.
==================== Disposal Considerations ====================
Waste Disposal Methods:PROCESSING, USE OR CONTAMINATION OF THIS PRODUCT
MAY CHANGE THE WASTE MANAGEMENT OPTIONS. STATE AND LOCAL DISPOSAL
REGULATIONS MAY DIFFER FROM FEDERAL DISPOSAL REGULATIONS. DISPOSE
OF CONTAINER AND UN USED CONTENTS IN ACCORDANCE WITH FEDERAL, STATE
AND LOCAL REQUIREMENTS.
=================== MSDS Transport Information ===================
Transport Information:DOT & IMO: PROPER SHIPPING NAME: BARIUM NITRATE,
HAZARD CLASS: 5.1, 6.1; UN/NA: UN1446; PACKING GROUP II.
===================== Regulatory Information =====================
SARA Title III Information:SARA 313: BARIUM NITRATE (10022-31-8),
CHEMICAL CATEGORY: BARIUM COMPOUND. SARA 311/312: ACUTE- YES.
CHRONIC- YES. FIRE- NO. PRESSURE- NO. REACTIVITY- NO.
Federal Regulatory Information:CERCLA, RCRA, & TSCA: NO.
======================= Other Information =======================
Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.